IQVIA Report Highlights EU’s Chance to Cultivate Sustainable Biosimilar Competition
The European Union (EU) is in the process of reviewing its pharmaceutical legislation, and a recent IQVIA white paper titled "Assessing the Biosimilar Void"...
IQVIA Report Highlights EU’s Chance to Cultivate Sustainable Biosimilar Competition